Why is fair value unavailable for Aryx Therapeutics, I (OTC-ARYX) stock?

A reliable fair value estimate is not currently available for Aryx Therapeutics, I (OTC-ARYX). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

What is the market capitalization of Aryx Therapeutics, I?

The current market capitalization listed for Aryx Therapeutics, I is 0.033 K.

What is the ticker symbol for Aryx Therapeutics, I?

The ticker symbol for Aryx Therapeutics, I is OTC-ARYX, and the stock is listed on OTC Markets.

Where is Aryx Therapeutics, I (OTC-ARYX) listed?

Aryx Therapeutics, I (OTC-ARYX) is listed on OTC Markets.

Aryx Therapeutics, I (ARYX) Fair Value & Stock Analysis

Aryx Therapeutics, I (ARYX)

ARYx Therapeutics, Inc. is a healthcare company focused on discovering and developing novel therapies for chronic conditions, with an emphasis on oral treatments. The company uses the RetroMetabolic Drug Design platform to create structurally distinct molecules intended to preserve the activity of original drugs while improving therapeutic properties. Its clinical-stage portfolio includes Tecarfarin (ATI-5923), an oral anticoagulant in Phase III development for patients at risk of dangerous blood clots; Budiodarone (ATI-2042), an oral antiarrhythmic in Phase IIb for atrial fibrillation; ATI-7505, an oral prokinetic candidate in Phase IIb for gastrointestinal and related disorders; and ATI-9242, an antipsychotic in Phase I development for schizophrenia and other psychiatric conditions. The pipeline also includes discovery-stage programs ATI-20,000 for metabolic disorders and ATI-24,000 for gastrointestinal disorders. The company was founded in 1997 and is based in Fremont, California.

Stock Summary Fair Value Profitability & Growth Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Market Cap
OTC-ARYX	Not available	Not available	Not available	0.033 K

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: daily • daily

Strong Sell

The daily technical read for Aryx Therapeutics, I (OTC-ARYX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: weekly • weekly

Strong Sell

The weekly technical read for Aryx Therapeutics, I (OTC-ARYX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: monthly • monthly

Strong Sell

The monthly technical read for Aryx Therapeutics, I (OTC-ARYX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Aryx Therapeutics, I (ARYX)

Stock Summary

Aryx Therapeutics, I (OTC-ARYX) Fair Value by Valuation Model

Fair Value

Analyst Price Target

How to read these valuation models

Profitability & Growth for Aryx Therapeutics, I (OTC-ARYX)

EBITDA

How to read profitability and growth

Technical Signals by Time Frame

Technical Signals by Time Frame

Aryx Therapeutics, I (OTC-ARYX) Stock FAQ

Similar Pharmaceuticals Stocks View more on OTC Markets